Consumer ProductsCompany
Mydecine Innovations Group M&A Summary
Mydecine Innovations Group has acquired 4 companies, including 4 in the last 5 years. It has also divested 1 asset.
Mydecine Innovations Group’s largest acquisition to date was in 2020, when it acquired Mindleap Health for $3M. It’s largest disclosed sale occurred in 2022, when it sold Mindleap Health to PanGenomic Health for $3M. Mydecine Innovations Group has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include consumer products (50%) and life science (25%).
Mydecine Innovations Group Business Overview
Where is Mydecine Innovations Group headquartered?
Mydecine Innovations Group is headquartered in Vancouver, British Columbia.
What sector is Mydecine Innovations Group in?
Mydecine Innovations Group is a consumer products company.
When was Mydecine Innovations Group founded?
Mydecine Innovations Group was founded in 2013.
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity4
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 2
- M&A Buy/Sell Connections 1